FIELD: pharmacology.
SUBSTANCE: liquid pharmaceutical solution for injection contains ketoprofen, amitriptyline, oxymetazoline, polyol, Na citrate and water. The polyol is selected from polyethylene glycol, propylene glycol, glycofurol and diethylene glycol monomethyl ether. The pharmaceutical solution has a pH of 4.5 to 7.0.
EFFECT: injection solution of the invention is stable for 6 months when stored at a temperature between 2 and 30 degrees.
11 cl, 7 dwg, 3 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL CREAM COMPOSITION OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA | 2012 |
|
RU2648439C2 |
| STABLE INJECTABLE COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE | 2013 |
|
RU2666993C2 |
| PREPARATIONS OF THERMO-ABRASIVE HYDROGEL FOR APPLICATION IN TREATMENT OF UTERTAL DISORDERS | 2013 |
|
RU2635466C2 |
| HARD DRUG FORM CONTAINING ACTIVE AGENT WITH DISGUISED TASTE | 2007 |
|
RU2437657C2 |
| INJECTABLE PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL | 2013 |
|
RU2660356C2 |
| LIPOSOME FORMULATIONS | 2013 |
|
RU2680096C2 |
| OXYMETAZOLINE COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS | 2020 |
|
RU2820596C2 |
| RECOMBINANT MONOCLONAL ANTIBODY TO TNF-ALPHA AQUEOUS PHARMACEUTICAL COMPOSITION | 2016 |
|
RU2665966C2 |
| LIQUID SELF-FOAMING PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2093146C1 |
| PHARMACEUTICAL SOLUTION OF MELOXICAM AND GLYCINE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2008 |
|
RU2383344C2 |
